We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays.
- Authors
Lippi, Giuseppe; Salvagno, Gian Luca; Pegoraro, Manuela; Militello, Valentina; Caloi, Cecilia; Peretti, Angelo; Gaino, Stefania; Bassi, Antonella; Bovo, Chiara; Lo Cascio, Giuliana
- Abstract
Keywords: coronavirus; COVID-19; immunoassay EN coronavirus COVID-19 immunoassay 1156 1159 4 06/15/20 20200701 NES 200701 To the Editor, The recent emergence of 2019 coronavirus disease (COVID-19) in December 2019 in China, and its ensuing widespread propagation all around the world, have finally persuaded the World Health Organization (WHO) to upgrade COVID-19 from an epidemic to a pandemic disease [[1]]. These results are substantially aligned with those previously published using the same immunoassays by Padoan et al. [[5]], and especially by Jin et al. [[9]], who reported that positivity for anti-SARS-CoV-2 IgM and IgG antibodies was 50% and 95% using different CLIAs. Lancet 2020;395:1101-2. 5 Padoan A, Cosma C, Sciacovelli L, Faggian D, Plebani M. Analytical performances of a chemiluminescence immunoassay for 2019-nCov IgM/IgG and antibody kinetics.
- Subjects
IMMUNOGLOBULIN M; CHEMILUMINESCENCE immunoassay; COVID-19; IMMUNOGLOBULIN G; IMMUNE response
- Publication
Clinical Chemistry & Laboratory Medicine, 2020, Vol 58, Issue 7, p1156
- ISSN
1434-6621
- Publication type
Article
- DOI
10.1515/cclm-2020-0473